A REVIEW OF BLOCK PAIN RECEPTORS WITH PROLEVIATE

The activation of CB1 and CB2 inhibits the development of intracellular cAMP, for this reason resulting in a huge reduction on the excitatory impact within the neurons [88,89]. Moreover, the activation of CB2 can even further prevent the mast cell degranulation and the release of pro-inflammatory mediators, creating the reduction in pain sensation